ADA%20Diabetes%20Treatment%20Algorithm_0

ADA%20Diabetes%20Treatment%20Algorithm_0 - More. . ....

Info iconThis preview shows pages 1–3. Sign up to view the full content.

View Full Document Right Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: More. . . Copyright © 2006 by Therapeutic Research Center Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249 www.pharmacistsletter.com ~ www.prescribersletter.com Detail-Document #221103 − This Detail-Document accompanies the related article published in − PHARMACIST’S LETTER / PRESCRIBER’S LETTER November 2006 ~ Volume 22 ~ Number 221103 American Diabetes Association Treatment Algorithm for Type 2 Diabetes Diagnosis of type 2 diabetes Counsel patients regarding lifestyle modification (weight loss, exercise) (expected decrease in HbA1c 1-2%) and initiate metformin [ Glucophage , others] 500 mg once or twice daily, titrate to 850 mg to 1000 mg twice daily (expected decrease in HbA1c 1.5%) HbA1c 7% or greater three months later Add rosiglitazone [ Avandia ] or pioglitazone [ Actos ] (expected decrease in HbA1c 0.5-1.4%) or sulfonylurea (expected decrease in HbA1c 1.5%) or basal insulin (bedtime intermediate-acting insulin or bedtime or morning long-acting insulin) (expected decrease in HbA1c 1.5-2.5%) HbA1c 7% or greater three months later Add additional agent (glitazone or sulfonylurea or insulin) or intensify insulin for those on insulin* HbA1c 7% or greater three months later In patients not yet receiving insulin, add basal insulin or intensify insulin in those already receiving insulin* HbA1c 7% or greater three months later Metformin + intensive insulin with/without glitazone *When prandial rapid or very-rapid acting insulin is added, insulin secretagogues such as the sulfonylureas or the glinides (repaglinide, nateglinide) should be discontinued. • Consider insulin as initial therapy (with lifestyle modification) in patients with fasting glucose greater than 250 mg/dL or HbA1c greater than 10% or those with ketonuria or symptoms of hyperglycemia. • When initiating insulin, start with a bedtime dose of an intermediate-acting insulin or once-daily long-acting insulin. Initiate with 10 units or 0.2 units per kg. Check fasting glucose concentrations and increase by approximately 2 units (4 units if fasting glucoses are greater than 180 mg/dL) every 3 days, until fasting glucoses are less than 130 mg/dL. If HbA1c continues to be 7% or greater after 2 to 3 months, with well-controlled fasting glucose concentrations, consider checking pre-meal glucose concentrations. • The algorithm does not include pramlintide [ Symlin ], exenatide [ Byetta ], alpha-glucosidase inhibitors [ Precose, Glyset ], glinides [ Prandin, Starlix ], or sitagliptin [ Januvia ] due to generally lower overall affect on HbA1c, limited information, and/or cost. However, these agents may be appropriate for certain patients. ( Detail-Document #221103: Page 2 of 4) More. . ....
View Full Document

This note was uploaded on 02/18/2012 for the course PAS 600 - 601 taught by Professor Garrubba during the Fall '10 term at Chatham University.

Page1 / 4

ADA%20Diabetes%20Treatment%20Algorithm_0 - More. . ....

This preview shows document pages 1 - 3. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online